A detailed history of Hexagon Capital Partners LLC transactions in Genmab A/S stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 287 shares of GMAB stock, worth $5,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares
287
Previous 320 10.31%
Holding current value
$5,874
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$23.84 - $28.48 $786 - $939
-33 Reduced 10.31%
287 $6,000
Q2 2024

Jul 12, 2024

BUY
$25.13 - $30.27 $25 - $30
1 Added 0.31%
320 $8,000
Q4 2023

Feb 05, 2024

SELL
$27.94 - $35.44 $866 - $1,098
-31 Reduced 8.86%
319 $10,000
Q3 2023

Oct 23, 2023

SELL
$35.27 - $42.24 $811 - $971
-23 Reduced 6.17%
350 $12,000
Q2 2023

Jul 24, 2023

SELL
$37.4 - $42.94 $598 - $687
-16 Reduced 4.11%
373 $14,000
Q1 2023

Apr 24, 2023

SELL
$34.88 - $43.22 $1,813 - $2,247
-52 Reduced 11.79%
389 $14,000
Q4 2022

Jan 13, 2023

SELL
$33.8 - $47.06 $7,334 - $10,212
-217 Reduced 32.98%
441 $0
Q3 2022

Oct 17, 2022

SELL
$31.52 - $373.61 $1,449 - $17,186
-46 Reduced 6.53%
658 $21,000
Q2 2022

Jul 21, 2022

BUY
$26.83 - $38.57 $1,234 - $1,774
46 Added 6.99%
704 $23,000
Q3 2020

Nov 10, 2020

BUY
$33.07 - $38.68 $21,760 - $25,451
658 New
658 $22,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.